{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:52:12Z","timestamp":1782471132852,"version":"3.54.5"},"reference-count":61,"publisher":"National Institute for Health and Care Research","issue":"27","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["10\/71\/01"],"award-info":[{"award-number":["10\/71\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Advanced chronic kidney disease is common in older people and is frequently accompanied by metabolic acidosis. Oral sodium bicarbonate is used to treat this acidosis, but evidence is lacking on whether or not this provides a net gain in health or quality of life for older people.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n The objectives were to determine whether or not oral bicarbonate therapy improves physical function, quality of life, markers of renal function, bone turnover and vascular health compared with placebo in older people with chronic kidney disease and mild acidosis; to assess the safety of oral bicarbonate; and to establish whether or not oral bicarbonate therapy is cost-effective in this setting.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A parallel-group, double-blind, placebo-controlled randomised trial.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n The setting was nephrology and geriatric medicine outpatient departments in 27 UK hospitals.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n Participants were adults aged \u2265\u200960 years with advanced chronic kidney disease (glomerular filtration rate category 4 or 5, not on dialysis) with a serum bicarbonate concentration of <\u200922\u2009mmol\/l.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Eligible participants were randomised 1\u2009:\u20091 to oral sodium bicarbonate or matching placebo. Dosing started at 500\u2009mg three times daily, increasing to 1\u2009g three times daily if the serum bicarbonate concentration was <\u200922\u2009mmol\/l at 3 months.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n The primary outcome was the between-group difference in the Short Physical Performance Battery score at 12 months, adjusted for baseline. Other outcome measures included generic and disease-specific health-related quality of life, anthropometry, 6-minute walk speed, grip strength, renal function, markers of bone turnover, blood pressure and brain natriuretic peptide. All adverse events were recorded, including commencement of renal replacement therapy. For the health economic analysis, the incremental cost per quality-adjusted life-year was the main outcome.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n In total, 300 participants were randomised, 152 to bicarbonate and 148 to placebo. The mean age of participants was 74 years and 86 (29%) were female. Adherence to study medication was 73% in both groups. A total of 220 (73%) participants were assessed at the 12-month visit. No significant treatment effect was evident for the primary outcome of the between-group difference in the Short Physical Performance Battery score at 12 months (\u20130.4 points, 95% confidence interval \u20130.9 to 0.1 points; p<\/jats:italic>\u2009=\u20090.15). No significant treatment benefit was seen for any of the secondary outcomes. Adverse events were more frequent in the bicarbonate arm (457 vs. 400). Time to commencement of renal replacement therapy was similar in both groups (hazard ratio 1.22, 95% confidence interval 0.74 to 2.02; p<\/jats:italic>\u2009=\u20090.43). Health economic analysis showed higher costs and lower quality of life in the bicarbonate arm at 1 year, with additional costs of \u00a3564 (95% confidence interval \u00a388 to \u00a31154) and a quality-adjusted life-year difference of \u20130.05 (95% confidence interval \u20130.08 to \u20130.01); placebo dominated bicarbonate under all sensitivity analyses for incremental cost-effectiveness.<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n The trial population was predominantly white and male, limiting generalisability. The increment in serum bicarbonate concentrations achieved was small and a benefit from larger doses of bicarbonate cannot be excluded.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Oral sodium bicarbonate did not improve a range of health measures in people aged \u2265\u200960 years with chronic kidney disease category 4 or 5 and mild acidosis, and is unlikely to be cost-effective for use in the NHS in this patient group. Once other current trials of bicarbonate therapy in chronic kidney disease are complete, an individual participant meta-analysis would be helpful to determine which subgroups, if any, are more likely to benefit and which treatment regimens are more beneficial.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n Current Controlled Trials ISRCTN09486651 and EudraCT 2011-005271-16. The systematic review is registered as PROSPERO CRD42018112908.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment<\/jats:italic>; Vol. 24, No. 27. See the NIHR Journals Library website for further project information.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/hta24270","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T11:49:45Z","timestamp":1592826585000},"page":"1-90","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCT"],"prefix":"10.3310","volume":"24","clinical-trial-number":[{"clinical-trial-number":"isrctn09486651","registry":"10.18810\/isrctn","type":"results"},{"clinical-trial-number":"2011-005271-16","registry":"10.18810\/euctr","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1967-0990","authenticated-orcid":true,"given":"Miles D","family":"Witham","sequence":"first","affiliation":[{"name":"AGE Research Group, NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation, Trust, Newcastle upon Tyne, UK"},{"name":"Molecular and Clinical Medicine, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7275-8468","authenticated-orcid":true,"given":"Margaret","family":"Band","sequence":"additional","affiliation":[{"name":"Tayside Clinical Trials Unit, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0768-1844","authenticated-orcid":true,"given":"Huey","family":"Chong","sequence":"additional","affiliation":[{"name":"Health Economics Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7828-0610","authenticated-orcid":true,"given":"Peter T","family":"Donnan","sequence":"additional","affiliation":[{"name":"Division of Population Health and Genomics, Medical School, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-5247","authenticated-orcid":true,"given":"Geeta","family":"Hampson","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Metabolic Medicine, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8346-1109","authenticated-orcid":true,"given":"May Khei","family":"Hu","sequence":"additional","affiliation":[{"name":"NHS Grampian, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4868-0132","authenticated-orcid":true,"given":"Roberta","family":"Littleford","sequence":"additional","affiliation":[{"name":"University of Queensland, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5154-7351","authenticated-orcid":true,"given":"Edmund","family":"Lamb","sequence":"additional","affiliation":[{"name":"East Kent Hospitals University NHS Foundation Trust, Canterbury, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7652-1572","authenticated-orcid":true,"given":"Philip A","family":"Kalra","sequence":"additional","affiliation":[{"name":"Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9856-3236","authenticated-orcid":true,"given":"Gwen","family":"Kennedy","sequence":"additional","affiliation":[{"name":"The Immunoassay Biomarker Core Laboratory, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4540-8718","authenticated-orcid":true,"given":"Paul","family":"McNamee","sequence":"additional","affiliation":[{"name":"Health Economics Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7478-7913","authenticated-orcid":true,"given":"Deirdre","family":"Plews","sequence":"additional","affiliation":[{"name":"Tayside Clinical Trials Unit, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4994-155X","authenticated-orcid":true,"given":"Petra","family":"Rauchhaus","sequence":"additional","affiliation":[{"name":"Tayside Clinical Trials Unit, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1397-4272","authenticated-orcid":true,"given":"Roy L","family":"Soiza","sequence":"additional","affiliation":[{"name":"Ageing Clinical and Experimental Research, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6832-3063","authenticated-orcid":true,"given":"Deepa","family":"Sumukadas","sequence":"additional","affiliation":[{"name":"Department of Medicine for the Elderly, NHS Tayside, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-015X","authenticated-orcid":true,"given":"Graham","family":"Warwick","sequence":"additional","affiliation":[{"name":"John Walls Renal Unit, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4813-5628","authenticated-orcid":true,"given":"Alison","family":"Avenell","sequence":"additional","affiliation":[{"name":"Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2020,6]]},"reference":[{"key":"key20200619104647722_ref1-bib1","unstructured":"Public Health England. Chronic Kidney Disease Prevalence Model. London: Public Health England; 2015. URL: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/612303\/ChronickidneydiseaseCKDprevalencemodelbriefing.pdf (accessed 6 January 2019)."},{"key":"key20200619104647722_ref1-bib2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key20200619104647722_ref1-bib3","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"key20200619104647722_ref1-bib4","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/j.1523-1755.2004.00481.x","article-title":"Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease","volume":"65","author":"Eustace","year":"2004","journal-title":"Kidney Int"},{"key":"key20200619104647722_ref1-bib5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1053\/j.ajkd.2010.03.023","article-title":"Serum bicarbonate and long-term outcomes in CKD","volume":"56","author":"Menon","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"key20200619104647722_ref1-bib6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1053\/j.ajkd.2014.05.009","article-title":"Serum bicarbonate concentrations and kidney disease progression in community-living elders: the Health, Aging, and Body Composition (Health ABC) Study","volume":"64","author":"Goldenstein","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"key20200619104647722_ref1-bib7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1053\/j.ajkd.2015.03.032","article-title":"Serum bicarbonate and kidney disease progression and cardiovascular outcome in patients with diabetic nephropathy: a post hoc analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) study and IDNT (Irbesartan Diabetic Nephropathy Trial)","volume":"66","author":"Schutte","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"key20200619104647722_ref1-bib8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1053\/j.ajkd.2014.05.008","article-title":"Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"64","author":"Driver","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"key20200619104647722_ref1-bib9","doi-asserted-by":"publisher","first-page":"F830","DOI":"10.1152\/ajprenal.00587.2010","article-title":"Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone","volume":"300","author":"Wesson","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20200619104647722_ref1-bib10","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2215\/CJN.00380118","article-title":"Effect of treatment of metabolic acidosis on vascular endothelial function in patients with CKD: a pilot randomized cross-over study","volume":"13","author":"Kendrick","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20200619104647722_ref1-bib11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.ackd.2017.06.005","article-title":"Adverse effects of the metabolic acidosis of chronic kidney disease","volume":"24","author":"Kraut","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"key20200619104647722_ref1-bib12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","article-title":"Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"62","author":"Dobre","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"key20200619104647722_ref1-bib13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.mayocp.2017.04.006","article-title":"Challenges in treating cardiovascular disease: restricting sodium and managing hyperkalemia","volume":"92","author":"Clegg","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"key20200619104647722_ref1-bib14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.ajkd.2010.12.021","article-title":"Association of serum bicarbonate levels with gait speed and quadriceps strength in older adults","volume":"58","author":"Abramowitz","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"key20200619104647722_ref1-bib15","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2215\/CJN.05480614","article-title":"Association of serum bicarbonate with incident functional limitation in older adults","volume":"9","author":"Yenchek","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20200619104647722_ref1-bib16","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1172\/JCI118566","article-title":"The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway","volume":"97","author":"Bailey","year":"1996","journal-title":"J Clin Invest"},{"key":"key20200619104647722_ref1-bib17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1681\/ASN.2006070771","article-title":"Metabolic bone disease in chronic kidney disease","volume":"18","author":"Martin","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key20200619104647722_ref1-bib18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1053\/j.ajkd.2014.07.007","article-title":"Serum bicarbonate and bone mineral density in US adults","volume":"65","author":"Chen","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"key20200619104647722_ref1-bib19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000365089","article-title":"Association of serum bicarbonate with bone fractures in hemodialysis patients: the mineral and bone disorder outcomes study for Japanese CKD category 5D patients (MBD-5D)","volume":"128","author":"Kato","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"key20200619104647722_ref1-bib20","first-page":"116","article-title":"Predictors of bone mineral density in dialyzed and non-dialyzed patients with chronic kidney disease","volume":"26","author":"Grzegorzewska","year":"2010","journal-title":"Adv Perit Dial"},{"key":"key20200619104647722_ref1-bib21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8020208","article-title":"Oral bicarbonate therapy in chronic kidney disease: a systematic review and meta-analysis of randomised controlled trial","author":"Hu","year":"2019","journal-title":"J Clin Med"},{"key":"key20200619104647722_ref1-bib22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08860220500461187","article-title":"Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial","volume":"28","author":"Mathur","year":"2006","journal-title":"Ren Fail"},{"key":"key20200619104647722_ref1-bib23","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status","volume":"20","author":"de Brito-Ashurst","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key20200619104647722_ref1-bib24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ki.2010.129","article-title":"Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy","volume":"78","author":"Mahajan","year":"2010","journal-title":"Kidney Int"},{"key":"key20200619104647722_ref1-bib25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/ki.2014.83","article-title":"Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate","volume":"86","author":"Goraya","year":"2014","journal-title":"Kidney Int"},{"key":"key20200619104647722_ref1-bib26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5049\/EBP.2014.12.2.80","article-title":"Effect of bicarbonate supplementation on renal function and nutritional indices in predialysis advanced chronic kidney disease","volume":"12","author":"Jeong","year":"2014","journal-title":"Electrolyte Blood Press"},{"key":"key20200619104647722_ref1-bib27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12882-016-0372-x","article-title":"Correction of metabolic acidosis improves insulin resistance in chronic kidney disease","volume":"17","author":"Bellasi","year":"2016","journal-title":"BMC Nephrol"},{"key":"key20200619104647722_ref1-bib28","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy214","article-title":"Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial [published online ahead of print 24 July 2018]","author":"Dubey","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"key20200619104647722_ref1-bib29","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.ajkd.2005.03.003","article-title":"Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment","volume":"45","author":"Kraut","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"key20200619104647722_ref1-bib30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ageing\/afu113","article-title":"Much more medicine for the oldest old: trends in UK electronic clinical records","volume":"44","author":"Melzer","year":"2015","journal-title":"Age Ageing"},{"key":"key20200619104647722_ref1-bib31","first-page":"1","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"KDIGO 2012","year":"2013","journal-title":"Kidney Int Suppls"},{"key":"key20200619104647722_ref1-bib32","unstructured":"National Institute for Health and Care Excellence (NICE). Chronic Kidney Disease in Adults: Assessment and Management. Clinical guideline CG182. London: NICE; 2015. URL: www.nice.org.uk\/guidance\/cg182 (accessed 6 January 2019)."},{"key":"key20200619104647722_ref1-bib33","doi-asserted-by":"publisher","first-page":"e0169548","DOI":"10.1371\/journal.pone.0169548","article-title":"Health outcomes of sarcopenia: a systematic review and meta-analysis","volume":"12","author":"Beaudart","year":"2017","journal-title":"PLOS ONE"},{"key":"key20200619104647722_ref1-bib34","volume-title":"Chronic Kidney Disease in England: The Human and Financial Cost","author":"Kerr","year":"2012"},{"key":"key20200619104647722_ref1-bib35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s13063-015-0843-6","article-title":"Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial","volume":"16","author":"Witham","year":"2015","journal-title":"Trials"},{"key":"key20200619104647722_ref1-bib36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"key20200619104647722_ref1-bib37","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.m85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"key":"key20200619104647722_ref1-bib38","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJM199503023320902","article-title":"Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability","volume":"332","author":"Guralnik","year":"1995","journal-title":"N Engl J Med"},{"key":"key20200619104647722_ref1-bib39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1532-5415.2010.02820.x","article-title":"Performance measures predict onset of activity of daily living difficulty in community-dwelling older adults","volume":"58","author":"Wennie Huang","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"key20200619104647722_ref1-bib40","first-page":"919","article-title":"The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure","volume":"132","author":"Guyatt","year":"1985","journal-title":"Can Med Assoc J"},{"key":"key20200619104647722_ref1-bib41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ageing\/afr051","article-title":"A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach","volume":"40","author":"Roberts","year":"2011","journal-title":"Age Ageing"},{"key":"key20200619104647722_ref1-bib42","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.ki.5002585","article-title":"A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease","volume":"73","author":"Fouque","year":"2008","journal-title":"Kidney Int"},{"key":"key20200619104647722_ref1-bib43","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"key20200619104647722_ref1-bib44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF00451725","article-title":"Development of the kidney disease quality of life (KDQOL) instrument","volume":"3","author":"Hays","year":"1994","journal-title":"Qual Life Res"},{"key":"key20200619104647722_ref1-bib45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2165\/11594150-000000000-00000","article-title":"Assessing quality of life among British older people using the ICEPOP CAPability (ICECAP-O) measure","volume":"9","author":"Flynn","year":"2011","journal-title":"Appl Health Econ Health Policy"},{"key":"key20200619104647722_ref1-bib46","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","article-title":"Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D","volume":"14","author":"Walters","year":"2005","journal-title":"Qual Life Res"},{"key":"key20200619104647722_ref1-bib47","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.amjmed.2012.11.032","article-title":"Effect of spironolactone on physical performance in older people with self-reported physical disability","volume":"126","author":"Burton","year":"2013","journal-title":"Am J Med"},{"key":"key20200619104647722_ref1-bib48","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1503\/cmaj.061339","article-title":"Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial","volume":"177","author":"Sumukadas","year":"2007","journal-title":"CMAJ"},{"key":"key20200619104647722_ref1-bib49","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1001\/jamainternmed.2013.9043","article-title":"Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial","volume":"173","author":"Witham","year":"2013","journal-title":"JAMA Intern Med"},{"key":"key20200619104647722_ref1-bib50","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W","article-title":"Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation","volume":"6","author":"Briggs","year":"1997","journal-title":"Health Econ"},{"key":"key20200619104647722_ref1-bib51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hec.4730030505","article-title":"Costs, effects and the C\/E ratios alongside a clinical trial","volume":"3","author":"van Hout","year":"1994","journal-title":"Health Econ"},{"key":"key20200619104647722_ref1-bib52","doi-asserted-by":"publisher","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"7","author":"Schulz","year":"2010","journal-title":"PLOS Med"},{"key":"key20200619104647722_ref1-bib53","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1532-5415.2006.00701.x","article-title":"Meaningful change and responsiveness in common physical performance measures in older adults","volume":"54","author":"Perera","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"key20200619104647722_ref1-bib54","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fphys.2017.00240","article-title":"Caffeine and bicarbonate for speed: a meta-analysis of legal supplements potential for improving intense endurance exercise performance","volume":"8","author":"Christensen","year":"2017","journal-title":"Front Physiol"},{"key":"key20200619104647722_ref1-bib55","unstructured":"Melamed ML, Horwitz EJ, Dobre MA, Abramowitz MK, Lo Y, Hostetter TH. The Effects of Sodium Bicarbonate in CKD Categories 3 and 4: A Randomized, Placebo-controlled, Multi-center Clinical Trial. American Society of Nephrology Kidney Week, San Diego, CA, USA, 23\u201328 October 2018. Abstract SA-OR037."},{"key":"key20200619104647722_ref1-bib56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5301\/jn.5000014","article-title":"A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) study","volume":"25","author":"Di Iorio","year":"2012","journal-title":"J Nephrol"},{"key":"key20200619104647722_ref1-bib57","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1745-6215-14-196","article-title":"Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study)","volume":"14","author":"Gaggl","year":"2013","journal-title":"Trials"},{"key":"key20200619104647722_ref1-bib58","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/ageing\/afx153","article-title":"Conducting and reporting trials for older people","volume":"46","author":"Witham","year":"2017","journal-title":"Age Ageing"},{"key":"key20200619104647722_ref1-bib59","unstructured":"Department of Health and Social Care (DHSC). NHS Reference Costs 2016\u201317. London: DHSC; 2017. URL: https:\/\/improvement.nhs.uk\/documents\/3479\/201617_ReferenceCostData.zip"},{"key":"key20200619104647722_ref1-bib60","volume-title":"Unit Costs of Health and Social Care 2017","author":"Curtis","year":"2017"},{"key":"key20200619104647722_ref1-bib61","unstructured":"National Institute for Health and Care Excellence (NICE). Home Care for Older People. Quality standard QS123. London: NICE; 2016. URL: www.nice.org.uk\/guidance\/qs123 (accessed 19 January 2019)."}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2032795","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2032795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:57:09Z","timestamp":1692115029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta24270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":61,"journal-issue":{"issue":"27","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["10.3310\/hta24270"],"URL":"https:\/\/doi.org\/10.3310\/hta24270","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"10-2012","name":"contractual_start_date","label":"Contractual start date","group":{"name":"article_history","label":"Article History"}},{"value":"2-2019","name":"editorial_review_begun","label":"Editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"9-2019","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}